The 20 Best Teratoma of the Mediastinum Doctors Near Me in Bronx, NY

Darren Feldman is an Oncologist practicing medicine in New York, New York. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Testicular Cancer, Teratoma of the Mediastinum, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy. Dr. Feldman is currently accepting new patients.

Joel Sheinfeld is a Urologist practicing medicine in New York, New York. Dr. Sheinfeld is rated as an Elite provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Testicular Cancer, Teratoma of the Mediastinum, Choriocarcinoma, Orchiectomy, and Lymphadenectomy. Dr. Sheinfeld is currently accepting new patients.

Dean Bajorin is an Oncologist practicing medicine in New York, New York. Dr. Bajorin is rated as an Elite provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Nephrectomy. Dr. Bajorin is currently accepting new patients.

George Bosl is an Oncologist practicing medicine in New York, New York. Dr. Bosl is rated as an Elite provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Teratoma of the Mediastinum, Testicular Cancer, Mediastinal Tumor, Choriocarcinoma, and Orchiectomy.

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Nephrectomy, and Prostatectomy.

Adam Levy, MD, is a Clinical Professor who works per diem at Montefiore Einstein in the trainee’s clinic. He specializes in general pediatric hematology and oncology, with a focus on tumors of the brain and spine, solid tumors and tumors associated with neurofibromatosis. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis, Glioma, Spinal Fusion, and Laminectomy.

Deaglan Mchugh is an Oncologist practicing medicine in New York, New York. Dr. Mchugh is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Teratoma of the Mediastinum, and Prostatectomy. Dr. Mchugh is currently accepting new patients.

Tarek Elrafei is an Oncologist practicing medicine in Bronx, New York. Dr. Elrafei is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Breast Cancer, Bone Marrow Aspiration, and Thrombectomy.

Guarionex Decastro is a Urologist practicing medicine in New York, New York. Dr. Decastro is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Decastro is currently accepting new patients.

Dr. Stein is an Associate Professor of Medical Oncology at Columbia University Medical Center. He is a recognized expert in field of genitourinary oncology – treating patients with prostate, kidney, bladder and testicular cancers. He is also a member of the Experimental Therapeutics program, investigating novel therapies across all solid tumors. In addition to providing standard therapies for the treatment of genitourinary cancers such as hormonal therapy, molecularly targeted therapy and chemotherapy, Dr. Stein leads multiple investigator initiated and industry sponsored clinical trials. Dr. Stein has a particular interest in the development of novel immune therapies for the treatment of prostate cancer, both in men with early recurrence of prostate cancer as well as in men with more advanced prostate cancer. He is also helping to lead two national trials in kidney cancer sponsored by the National Cancer Institute.Dr. Stein received his B.S. in Molecular Biophysics and Biochemistry from Yale University. He earned his medical degree at New York Medical College, receiving the graduation award in oncology for his published research. He completed a residency in internal medicine at Montefiore Medical Center, and a fellowship in Hematology and Medical Oncology at Mount Sinai Medical Center. Prior to joining Columbia University, Dr. Stein practiced genitourinary oncology for 13 years at Rutgers University and has been an author on over 60 publications including guidelines for assessing the efficacy of new drugs in prostate cancer and recommendations for the use of immunotherapy to treat prostate cancer. Dr. Stein is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), and Familial Prostate Cancer. Dr. Stein is board certified in Medical Oncology. Dr. Stein is currently accepting new patients.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.

Myron M. Studner Professor of Cancer Research and Professor of Medicine and Epidemiology at Columbia University, Associate Director for Population Science, Leader of the Prevention, Control, and Disparities Program for the Herbert Irving Comprehensive Cancer Center at Columbia, and Co-Director of the Cancer Prevention Center of New York Presbyterian Hospital Dr. Neugut is a medical oncologist with a particular interest in gastroIntestinal tract cancers, especially of colorectal and gasteric cancers. Under the auspices of Columbia's MD/PhD program, he received his MD and a PhD in Pathobiology in 1977. He did his training in Internal Medicine at the Albert Einstein College of Medicine and fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center. He returned to Columbia University as an Andrew Mellon Fellow in Epidemiology and Medicine to obtain an MPH in Epidemiology in 1983. Dr. Neugut then joined the faculty at Columbia University with appointments in Medicine and Epidemiology.As both a practicing medical oncologist and cancer epidemiologist, Dr. Alfred Neugut's major interests have been on GI tract cancers, notably the epidemiology of colorectal adenomas and cancer, as well as colonoscopic screening. He serves as co-principal investigator of the Long Island Breast Cancer Study Project, a large multi-center effort to explore environmental causes of breast cancer on Long Island. Most recently, his efforts have focused on more clinical topics, such as the epidemiology of second malignancies and the use of chemotherapy and radiation therapy among elderly cancer patients. Dr. Neugut focuses a great deal on racial disparities in incidence and survival from cancer and, in particular, variations across subgroups of people of African descent. He leads two large training grants in cancer-related population sciences that together fund 15 pre and postdoctoral trainees in cancer epidemiology, biostatistics, and environmental health sciences, and serves as a mentor to a number of junior faculty. Dr. Neugut is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Breast Cancer, Familial Colorectal Cancer, Endoscopy, and Colonoscopy. Dr. Neugut is board certified in Internal Medicine and Medical Oncology. Dr. Neugut is currently accepting new patients.

June Y. Hou, MD is an Associate Professor of Obstetrics & Gynecology at the Columbia University Medical Center. Dr. Hou received her undergraduate degree at Yale College with Honors, and completed medical school at Georgetown University School of Medicine. After completing her residency training at Yale New Haven Hospital, she pursued a gynecologic oncology fellowship at Albert Einstein College of Medicine, Montefiore Medical Center. She is board certified in Obstetrics and Gynecology and Gynecologic Oncology, and also has a Master Degree of Business Administration from Columbia Business School.She joins the faculty at Columbia University Medical Center with a research interest in promoting equity and diversity in clinical trials, and quality of life measures in clinical trial participants. Her clinical interest encompasses expanding awareness of heredity gynecological cancers and access to care, along with clinical outreach. A past recipient of a career development grant focusing on molecular pathogenesis of ovarian cancer and rare uterine cancers, Dr. Hou has given numerous nationally-recognized presentations based on her work, and has led numerous clinical trials. Clinically, Dr. Hou is certified in minimally invasive surgery, including robotic-assisted surgery. Her expertise includes novel and traditional chemotherapeutics and complex pelvic surgeries. Her goal is to provide compassionate and individualized care to all women with pre-malignant or gynecological cancers. Dr. Hou is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Sertoli-Leydig Cell Tumor, Hysterectomy, and Oophorectomy. Dr. Hou is board certified in Obstetrics And Gynecology and Hospice And Palliative Medicine. Dr. Hou is currently accepting new patients.

Stephen Trauzzi is a Urologist practicing medicine in New Rochelle, New York. Dr. Trauzzi is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Prostatectomy, and Ureteroscopy. Dr. Trauzzi is board certified in American Board Of Urology.

Lee Richstone, MD is the Chairman of Urology and Director of Urology Services for the Western Region. He is also Director of Laparoscopic and Robotic Surgery at Lenox Hill Hospital and System Vice Chairman for Education for Northwell Health Urology. Dr. Richstone is Professor of Urology at The Hofstra-Northwell School of Medicine. Dr. Richstone completed medical school at the Cornell University Medical College in New York City. There he won early acceptance into Alpha Omega Alpha (AOA), the prestigious national medical honor society. He pursued his urologic training and chief residency at New York Presbyterian (Weill-Cornell) and Memorial Sloan Kettering hospitals. Dr. Richstone completed his fellowship training in urologic laparoscopic and robotic surgery and joined the North Shore Long Island Jewish Health System in 2007 as Director of Laparoscopic and Robotic Surgery. He then served as Chief of Urology for the North Shore University Hospital, then Chief of Urology at the Long Island Jewish Medical Center, before assuming the role of Chairman of Urology at Lenox Hill Hospital in Manhattan. Dr. Richstone is an internationally recognized urologic surgeon who has helped pioneer laparoscopic and robotic surgery for cancer of the prostate, kidney and bladder, as well as for various forms of urinary obstructions. He has over 90 peer-reviewed publications in leading national and international journals including The Journal of Urology, Urology, The British Journal of Urology, The Journal of Endourology, Cancer, and Cell.Dr. Richstone is a robotic surgery specialist having performed well over 1000 operations. This includes surgeries for prostate, kidney and bladder cancer and complex neobladder reconstructions completely robotically. His focus is on preserving urinary continence and sexual function. Dr. Richstone has also pioneered Laparoendoscopic Single Site Surgery (LESS), where entire laparoscopic operations are performed only through the belly button. Dr. Richstone is one of only a few surgeons in the United States to have performed single site partial nephrectomy and prostatectomy.Dr. Richstone is a member of the Society of Urologic Oncology (SUO), the America Urological Association (AUA), and the Endourological Society (EUS). Dr. Richstone is the recipient of numerous honors and awards, including acceptance into Alpha Omega Alpha (AOA), the E. Darracott Vaughan Prize for Excellence in Urology (2000), The Ferdinand C. Valentine Urology Essay Prize (First Place, 2005), The American Urological Association-Ambrose Reed Socioeconomic Essay Contest (First Place, 2005), and the Weill-Cornell Distinguished House Officer Award (2005). Dr. Richstone was awarded the Stryker and Nagamatsu Fellowship (2007), and won first prize at the Endourology Society Fellowship Paper Award the same year. Dr. Richstone won first prize at the AUA Research Foundation for Outstanding Research awarded at the 2010 AUA National Meeting in San Francisco. Dr. Richstone is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Richstone is board certified in American Board Of Urology.

Brett Carver is a Urologist practicing medicine in New York, New York. Dr. Carver is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Testicular Cancer, Prostate Cancer, Teratoma of the Mediastinum, Orchiectomy, and Prostatectomy. Dr. Carver is currently accepting new patients.

Robert Motzer is an Oncologist practicing medicine in New York, New York. Dr. Motzer is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Teratoma of the Mediastinum, Nephrectomy, and Orchiectomy. Dr. Motzer is currently accepting new patients.

Samuel Funt is an Oncologist practicing medicine in New York, New York. Dr. Funt is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Testicular Cancer, Teratoma of the Mediastinum, Bladder Cancer, and Orchiectomy. Dr. Funt is currently accepting new patients.

Leonard Glickman is a Urologist practicing medicine in New York, New York. Dr. Glickman is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Obstructive Uropathy, UPJ Obstruction, Enlarged Prostate (BPH), Ureteroscopy, and Nephrectomy. Dr. Glickman is board certified in American Board Of Urology.

Bob Berookhim, MD is the Director of Male Fertility and Microsurgery at Lenox Hill Hospital. He is a board certified urologist and assistant professor of urology at the Zucker School of Medicine. He specializes in male reproductive medicine, microsurgery and sexual medicine. His primary focus is on the medical and surgical management of male infertility, erectile dysfunction, Peyronie s disease, and low testosterone, as well as enlarged prostate (BPH), and urinary stone disease.Dr. Berookhim is an expert in microsurgical vasectomy reversals, microdissection testicular sperm extraction, microsurgical varicocelectomy, penile implants for erectile dysfunction, surgical treatment for Peyronie s disease, male fertility preservation and minimally invasive endoscopic surgery to treat benign prostatic hyperplasia and kidney stones. In addition to delivering exceptional surgical care to his patients, he provides state of the art evidence based medical treatments for male factor infertility and male sexual dysfunction. He also has extensive experience in the management of general urological conditions.Dr. Berookhim is a graduate of the highly competitive Seven Year Accelerated Liberal Arts and Medical Education (B.A./M.D.) program at Boston University, having gained admission to medical school immediately after high school. He completed an internship in Surgery and residency in Urology at the Mount Sinai School of Medicine. Additionally he completed prestigious fellowships in Male Sexual and Reproductive Medicine at the Memorial Sloan Kettering Cancer Center and in Male Reproductive Medicine and Microsurgery at the Weill Cornell Medical College. He is the co-author of many internationally published studies addressing a myriad of men s health issues including erectile dysfunction, Peyronie s disease, hypogonadism and male infertility, and has presented numerous abstracts at influential medical society meetings. He also serves as a peer reviewer for the Journal of Urology, American Journal of Men s Health, Journal of Assisted Reproduction and Genetics, and the Middle East Fertility Society Journal. Dr. Berookhim is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Peyronie Disease, Varicocele, Testicular Failure, Hormone Replacement Therapy (HRT), and Ureteroscopy. Dr. Berookhim is board certified in American Board Of Urology.